基本信息
views: 1097
Career Trajectory
Bio
More recently, his clinical innovations have been in the development of the breakthrough monoclonal antibodies elotuzumab and daratumumab for the treatment of both untreated and relapsed myeloma, as well as isatuximab and more broadly, antibody drug conjugates including belantamab mafodotin, as well as other immunotherapeutic strategies. In addition to these agents, he is leading the development of melflufen, a targeted cytotoxic and a first-in-class small molecule inhibitor selinexor, which inhibits XPO-1, a key nuclear export protein, as well as first-in-human studies of cereblon E3 ligase modulators (so called CELMoDs) for the treatment of relapsed and refractory myeloma. Over the last decade, his major effort has been focused on the development of lenalidomide, bortezomib and dexamethasone (so-called RVD), and its incorporation as part of the Intergroup Francophone Myelome (IFM)/DFCI clinical trial in newly diagnosed patients eligible for stem cell transplant treated with RVD
Research Interests
Papers共 1366 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Natalie S. Callander,Rebecca Silbermann,Jonathan L. Kaufman,Kelly N. Godby,Jacob Laubach,Timothy M. Schmidt,Douglas W. Sborov,Eva Medvedova,Brandi Reeves,Binod Dhakal,Cesar Rodriguez,Saurabh Chhabra,Ajai Chari,Susan Bal,Larry D. Anderson,Bhagirathbhai R. Dholaria,Nitya Nathwani,Parameswaran Hari,Nina Shah,Naresh Bumma,Sarah A. Holstein,Caitlin Costello,Andrzej Jakubowiak,Tanya M. Wildes,Robert Z. Orlowski,Kenneth H. Shain,Andrew J. Cowan,Huiling Pei,Annelore Cortoos,Sharmila Patel,Thomas S. Lin,Smith Giri,Luciano J. Costa,Saad Z. Usmani,Paul G. Richardson,Peter M. Voorhees
Tondre Buck,Monique A. Hartley-Brown, Yvonne A. Efebera,Carter P. Milner,Jeffrey A. Zonder,Paul G. Richardson,Taylor Salinardi,Megan S. Rice
HAEMATOLOGICAno. 6 (2024): 1882-1892
LEUKEMIA (2024)
Oncogene (2024)
Ajai Chari,Jonathan L Kaufman,Jacob Laubach,Douglas W Sborov,Brandi Reeves,Cesar Rodriguez,Rebecca Silbermann,Luciano J Costa,Larry D Anderson,Nitya Nathwani,Nina Shah,Naresh Bumma,Sarah A Holstein,Caitlin Costello,Andrzej Jakubowiak,Tanya M Wildes,Robert Z Orlowski,Kenneth H Shain,Andrew J Cowan,Huiling Pei,Annelore Cortoos,Sharmila Patel,Thomas S Lin,Peter M Voorhees,Saad Z Usmani,Paul G Richardson
Blood cancer journalno. 1 (2024): 107-107
Annalisa Ruggeri,Francesco Corrado,Antonio Voza,Lee-Jen Wei,Gloria Catalano,Carmine Liberatore,Rosamaria Nitti,Carlo Fedeli,Alessandro Bruno,Eleonora Calabretta,Fabio Giglio,Fabio Sciutti,Francesca Lunghi,Giovanni Landoni,Alessio Aghemo,Massimo Iacobelli,Patrizia Rovere Querini,Paul G Richardson,Andrea Assanelli,Jacopo Peccatori,Fabio Ciceri,Carmelo Carlo-Stella
Haematologicano. 1 (2024)
HEMATOno. 2 (2024): 144-156
Fredrik H. Schjesvold,Heinz Ludwig,Sossana Delimpasi,Pawel Robak,Daniel Coriu,Waldemar Tomczak,Ludek Pour,Ivan Spicka,Meletios-Athanasios Dimopoulos,Tamas Masszi, Natalia G. Chernova,Anna Sandberg,Marcus Thuresson,Stefan Norin,Nicolaas A. Bakker,Maria-Victoria Mateos,Paul G. Richardson,Pieter Sonneveld
Haematologica (2024)
Marcello Turi,Eugenio Morelli, Megan Johnstone, Mehmet K. Samur,Cirino Botta, Selma Cifrić, Pietro Folino, Delaney Vinaixa, Francesca Barello, Cole Clericuzio, Vanessa Favasuli,Domenico Maisano, Srikanth Talluri, Rao Prabhala,Giada Bianchi,Mariateresa Fulciniti,Kenneth Wen,Keiji Kurata,Jiye Liu, Johany Penailillo,Alberto Bragoni,Anna Sapino,Paul G. Richardson,Dharminder Chauhan,Ruben D. Carrasco,Teru Hideshima,Nikhil C. Munshi,Kenneth C. Anderson,Annamaria Gullà
Blood cancer discoveryno. 2_Supplement (2024): P24-P24
Load More
Author Statistics
#Papers: 1359
#Citation: 105865
H-Index: 150
G-Index: 303
Sociability: 9
Diversity: 0
Activity: 9
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn